Augmerosen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Augmerosen, covering 2013-02-01 to 2013-02-01. Get the full timeline:
Most recent: Clinical Trial Update: Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1]